Go

Follow Us

COVAXIN

Latest News about COVAXIN

FDA to consider using Covaxin as vaccine candidate in US

Covaxin, Covishield get conditional market nod for inoculating adults

Regular market approval granted for Covishield, Covaxin for use in adult population

Each dose of Covishield, Covaxin likely to be capped at Rs 275 after getting regular market approval

Covaxin, Covishield okayed for regular market approval

Covaxin, Covishield cleared for full market approval

covid-19 pandemic

Covid vaccination for 12-14 age group likely from March, says top govt expert

70 pc adults fully vaccinated: Mandaviya at stamp launch to mark 1 year of Covid vaccination drive